Rosecliff Acquisition Corp I
RCLFU
NASDAQ Capital Market11.33
USD
+1.19
- -
Rosecliff Acquisition Corp I
RCLFU
(NASDAQ Capital Market)
Recent
price
11.33
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Rosecliff Acquisition Corp I (RCLFU) operates as a blank check company, or special purpose acquisition company (SPAC), whose primary purpose focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, particularly those in technology-enabled sectors such as financial services, consumer products, healthcare, and software. The company offers no operational products or services of its own prior to a business combination but holds investor capital in trust for deployment in a target acquisition; its units, each consisting of one Class A ordinary share and one-third of one redeemable warrant, provide public shareholders access to a de-SPAC transaction. Incorporated in 2020 and headquartered in New York, New York, Rosecliff Acquisition Corp I targets visionary leaders and serial entrepreneurs driving disruptive technologies across U.S. and potentially global markets. In September 2023, Rosecliff Acquisition Corp I completed a reverse merger business combination with Spectral MD Holdings Ltd., resulting in the combined entity renaming to Spectral AI Ltd. and listing its shares on the Nasdaq Global Market under the ticker MDAI, with RCLFU units ceasing active independent trading thereafter. This transaction, announced in April 2023, delivered gross proceeds exceeding $20 million to the combined company, including trust cash and private placement investments, to support Spectral AI's AI-driven medical diagnostics platform for wound care applications like burns and diabetic foot ulcers. The SPAC, sponsored by affiliates of Rosecliff Ventures—a New York-based investment firm founded in 2016 managing over $1 billion in assets across venture capital, growth equity, and credit strategies—previously priced a $220 million upsized IPO in February 2021.
Rosecliff Acquisition Corp I Announces the Separate Trading of its Class A Common Stock and Redeemable Warrants Commencing on or about March 26, 2021